[Edaily Reporter kyoungeun kim ] Shares of HansungEnterprise(003680), a company drawing market attention as a “patriotic enterprise,” have hit the daily price limit for two consecutive days. According to MP Doctor, as of 9:14 a.m. on the 10th, HansungEnterprise(003680)(003680) is trading at 8,460 won, up 1,950 won (29.95%) from the previous day. Following the previous day’s gains, the stock has hit the daily price limit for two consecutive days, continuing its upward trend for five trading days and nearly doubling in value. The so-called “donchul” craze—sparked by the revelation that HansungEnterprise, a seafood processing company famous for its “Kramy” brand, has sponsored concerts for UN war veterans for 25 years—shows no signs of abating in the stock market. Previously, HansungEnterprise posted sales of 320 billion won last year, but its operating profit was cut in half, causing its stock price to fall below the 4,000-won mark. When the Financial Services Commission raised the market capitalization threshold for delisting from the KOSPI to less than 30 billion won, HansungEnterprise—with a market cap of 26.1 billion won—was pushed to the brink of delisting. However, the situation reversed as heartwarming stories about the “patriotic company” spread rapidly online. Its market capitalization also surpassed 50 billion won, significantly exceeding the delisting threshold of 30 billion won. This is seen as evidence that the phenomenon of “value-driven consumption”—where a company’s social contribution activities lead to both consumption and investment—is emerging in the stock market. Nevertheless, investors are advised to exercise caution. Given that volatility may increase following a short-term surge, and that this rally is largely driven by speculative themes rather than confirmed improvements in fundamentals such as earnings, experts warn against chasing the rally.
The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …